Topics
Glioblastoma | Treatment | Clinical trials | Methoxyamine
Home > Publications > Topics > Glioblastoma > Treatment > Clinical trials > Methoxyamine
Ahluwalia
MS, Ozair A, Drappatz J, Ye X, Peng S, Lee M, Rath S, Dhruv H, Hao
Y, Berens ME, Walbert T, Holdhoff M, Lesser GJ, Cloughesy TF,
Sloan AE, Takebe N, Couce M, Peereboom DM, Nabors B, Wen PY,
Grossman SA, Rogers LR.
Evaluating
the Base Excision Repair Inhibitor TRC102 and Temozolomide for
patients with Recurrent Glioblastoma in the Phase 2 Adult Brain
Tumor Consortium Trial BERT.
Clin
Cancer Res.
2024 Jun 5. doi:
10.1158/1078-0432.CCR-23-4098. PMID:
38836759. Interventional study˰ ˍ